Tim Allen Obert, MS, CPS, SAC, CCDS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1307 State Road 69, New Glarus, WI 53574 Phone: 608-527-2401 Fax: 608-527-1939 |
Jennie R Bowyer Lcsw, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1307 State Road 69, New Glarus, WI 53574 Phone: 608-921-8493 |
Eric C Gebhart, B.S., CSAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1307 State Road 69, New Glarus, WI 53574 Phone: 608-527-2426 Fax: 608-527-1939 |
News Archive
New research by scientists at the University of North Carolina at Chapel Hill shows for the first time that an important family of proteins known to function at the cell surface also functions at a site within the cell.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNSĀ® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
As part of a multi-faceted initiative geared to significantly reduce college binge drinking and coinciding with National Collegiate Alcohol Awareness Week, The Century Council, a not-for-profit organization funded by distillers dedicated to fighting drunk driving and underage drinking, has provided a $100,000 research grant to the Emergency Medicine Foundation (EMF) to learn more about the role of emergency services with regard to college binge drinking.
As part of its ongoing work in the prevention and control of serious infections in healthcare settings, Roche announced today its sponsorship of the 3rd Annual World MRSA Day.
Merge Healthcare has successfully deployed its etrials eDiary 5.0 platform to conduct a global Phase II urology clinical trial involving 750 patients for one of the largest pharmaceutical companies in the world. Merge was awarded the project because of its eDiary technology, experience in global ePRO (electronic patient reported outcomes) trials and ability to manage the complex logic required by this study. Underway in 22 countries on 3 continents and in 34 languages, the trial also utilizes Merge's new eDiary Inventory Module to track shipping and supply of study devices in real-time.
› Verified 8 days ago